
ARMA Biosciences has developed a rapid, versatile sensor platform capable of continuous monitoring for a multitude of physiological markers. For example, indicators of heart failure progression, including NT-proBNP, CRP, and Cardiac Troponin I.
Faculty Founder
Shana Kelley, Neena B. Schwartz Professor of Chemistry and Biomedical Engineering

Flashpoint is developing nanotherapeutic candidates that can co-deliver precise RNA, DNA and peptide payloads to the right cells at the right time to treat various types of cancer including pancreatic, head/neck, cervical, and glioblastoma.
Faculty Founder
Chad Mirkin, George B. Rathmann Professor of Chemistry

HIDENN-AI is developing convolution hierarchical deep-learning neural networks to simultaneously train, solve, and calibrate any advanced materials and manufacturing system, reducing solution time and data storage by orders of magnitude.
Faculty Founder
Wing Kam Liu, Walter P. Murphy Professor of Mechanical Engineering & Civil and Environmental Engineering

ImmPro has developed a mass spectrometry platform, available as contract research services, that directly measures biologically significant differences between protein forms to advance diagnostics and therapeutics development.
Faculty Founder
Neil Kelleher, Professor of Chemistry, Weinberg College of Arts and Sciences

Laborecom Therapeutics
Laborecom Therapeutics is developing a peptide therapeutic to prevent long-term damage to the heart after a heart attack. By leveraging novel endothelial cell biology, they aim to reduce inflammatory cell accumulation, protect the heart from damage, and save patient lives.
Faculty Founder
William A. Muller, Janardan K. Reddy Professor of Pathology, Feinberg School of Medicine

Melanyze
Melanyze harnesses the power of synthetic melanin chemistry and biology to redefine skin regeneration and repair that address critical gaps in topical therapies.
Faculty Founder
Nathan Gianneschi, Jacob & Rosaline Cohn Professor of Chemistry, Materials Science & Engineering and Biomedical Engineering
Kurt Lu, Eugene and Gloria Bauer Professor of Dermatology

PreDx creates non-invasive gene therapy monitoring using our bio-responsive MR imaging agents allowing quantitative visualization of gene expression in real-time.
Faculty Founder
Thomas Meade, Professor of Chemistry

RMD Sciences is pioneering a novel Alzheimer’s disease therapy that selectively promotes the growth of specific gut flora to improve brain function.
Former NU Faculty Founder
Kazuhiro Shimomura

SNC Therapeutics is developing a rational immunotherapy platform utilizing scalable versatile synthetic nanocarriers (SNCs) for targeted drug delivery and transfection of diverse cell populations in autoimmune diseases.
Former NU Faculty Founder
Evan Scott, Thomas A. Saunders III Family Jefferson Scholars Foundation Distinguished University Professor, Biomedical Engineering (UVA)

Temprian Oncology develops highly selective supercarriers for the treatment of cutaneous and ocular melanoma.
Faculty Founders
Caroline LePoole, Professor of Dermatology
Sonbinh Nguyen, McCormick Professor of Teaching Excellence Dow Chemical Company Research Professor of Chemistry

Third Coast Dynamics
Third Coast is developing a cloud-based risk stratification tool for aortic diseases that uses artificial intelligence to provide hemodynamic imaging biomarkers from standard CT angiography and MR angiography images
Faculty Founders
Michael Markl, Vice Chair for Research, Department of Radiology, Lester B. and Frances T. Knight Professor of Cardiac Imaging
Bradley Allen, Chief of Cardiovascular and Thoracic Imaging in the Department of Radiology, Associate Professor, Radiology (Cardiovascular and Thoracic Imaging)